Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1260 publications

Ponatinib in the treatment of acute lymphoblastic leukemia.

Ponatinib in the treatment of acute lymphoblastic leukemia.

Journal: Future oncology (London, England)
Published: November 14, 2025

Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025.

Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025.

Journal: Hematology (Amsterdam, Netherlands)
Published: October 31, 2025

Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy.

Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy.

Journal: Current hematologic malignancy reports
Published: October 07, 2025

Oncologists' preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment.

Oncologists' preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment.

Journal: Future oncology (London, England)
Published: October 06, 2025

Vascular endothelial cells and angiogenesis.

Vascular endothelial cells and angiogenesis.

Journal: Pharmacological research
Published: October 04, 2025

Mechanisms of resistance to the allosteric BCR::ABL1 inhibitor asciminib

Mechanisms of resistance to the allosteric BCR::ABL1 inhibitor asciminib

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025

Microfluidic single-cell drug screening: toward personalized precision therapy in chronic myeloid leukemia.

Microfluidic single-cell drug screening: toward personalized precision therapy in chronic myeloid leukemia.

Journal: Lab on a chip
Published: September 29, 2025

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML.

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML.

Journal: Frontiers in oncology
Published: September 23, 2025

Under ONIOM Layers: Analysis of BCR-ABL Enzyme Inhibitors Through Bond-Critical Points and Natural Orbitals.

Under ONIOM Layers: Analysis of BCR-ABL Enzyme Inhibitors Through Bond-Critical Points and Natural Orbitals.

Journal: Molecules (Basel, Switzerland)
Published: September 17, 2025

How I treat Ph+ acute lymphoblastic leukemia.

How I treat Ph+ acute lymphoblastic leukemia.

Journal: Future oncology (London, England)
Published: September 08, 2025

Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective Cohort.

Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective Cohort.

Journal: The American Journal of dermatopathology
Published: September 08, 2025

Pregnancy-Related Adverse Events with Tyrosine Kinase Inhibitor Use in Chronic Myeloid Leukemia: A FAERS Pharmacovigilance Analysis (2001-2024).

Pregnancy-Related Adverse Events with Tyrosine Kinase Inhibitor Use in Chronic Myeloid Leukemia: A FAERS Pharmacovigilance Analysis (2001-2024).

Journal: Clinical lymphoma, myeloma & leukemia
Published: September 04, 2025
Showing 1-12 of 1,260

Last Updated: 01/07/2026